Physician profile
Jason Halvorson
NPI 1033316773
$197,323.16
in general payments reported to CMS, 2019-2025
8 companies · $132K in 2025
The $132K reported for 2025 was more than what 99% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $976 · 2020: $12K · 2021: $29.48 · 2022: $5,148 · 2023: $25K · 2024: $22K · 2025: $132K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $125K · Consulting Fee: $42K · Honoraria: $11K · Food and Beverage: $873.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $125,316.72 |
| Consulting Fee | $42,200.00 |
| Honoraria | $11,000.00 |
| Food and Beverage | $872.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $170,813.67 | 2020-2025 | Pangea, Axsos, Variax |
| Illuminoss Medical, INC. | $11,410.35 | 2019-2025 | Photodynamic Bone Stabilization Procedure Pack |
| Smith+Nephew, INC. | $8,708.35 | 2019-2020 | |
| Synthes Gmbh | $5,779.30 | 2020-2022 | |
| Depuy Synthes Sales INC. | $376.73 | 2019-2025 | Na, Va-Lcp, Lcp |
| Medical Device Business Services, INC. | $131.58 | 2019 | |
| Wishbone Medical INC. | $66.14 | 2023 | |
| Piedmont Plus Innovation | $37.04 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Halvorson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.